Collectively, these findings provide direct evidence that truncation of GSK-3β by overactivated calpain I results in the enhancement of its kinase activity and leads to abnormal hyperphosphorylation and pathology of tau in AD brain. The gene discussed is MAPT; the disease is Alzheimer disease.